136 related articles for article (PubMed ID: 7947796)
1. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
Jackson SE; Fersht AR
Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
[TBL] [Abstract][Full Text] [Related]
2. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
Longstaff C; Campbell AF; Fersht AR
Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
[TBL] [Abstract][Full Text] [Related]
3. Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg.
Osmark P; Sørensen P; Poulsen FM
Biochemistry; 1993 Oct; 32(41):11007-14. PubMed ID: 8218165
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
Kojima S; Nishiyama Y; Kumagai I; Miura K
J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
[TBL] [Abstract][Full Text] [Related]
5. Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2.
Radisky ES; Lu CJ; Kwan G; Koshland DE
Biochemistry; 2005 May; 44(18):6823-30. PubMed ID: 15865427
[TBL] [Abstract][Full Text] [Related]
6. Hydrolysis of small peptide substrates parallels binding of chymotrypsin inhibitor 2 for mutants of subtilisin BPN'.
Eder J; Rheinnecker M; Fersht AR
FEBS Lett; 1993 Dec; 335(3):349-52. PubMed ID: 8262182
[TBL] [Abstract][Full Text] [Related]
7. Selective removal of individual disulfide bonds within a potato type II serine proteinase inhibitor from Nicotiana alata reveals differential stabilization of the reactive-site loop.
Schirra HJ; Guarino RF; Anderson MA; Craik DJ
J Mol Biol; 2010 Jan; 395(3):609-26. PubMed ID: 19925809
[TBL] [Abstract][Full Text] [Related]
8. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
[TBL] [Abstract][Full Text] [Related]
9. Design of a small peptide-based proteinase inhibitor by modeling the active-site region of barley chymotrypsin inhibitor 2.
Leatherbarrow RJ; Salacinski HJ
Biochemistry; 1991 Nov; 30(44):10717-21. PubMed ID: 1931991
[TBL] [Abstract][Full Text] [Related]
10. Primary structure and inhibitory properties of a subtilisin-chymotrypsin inhibitor from Streptomyces virginiae.
Terabe M; Kojima S; Taguchi S; Momose H; Miura K
Eur J Biochem; 1994 Dec; 226(2):627-32. PubMed ID: 8001578
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
Braxton S; Wells JA
Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the propeptide of subtilisin E as an intramolecular chaperone for protein folding. Refolding and inhibitory abilities of propeptide mutants.
Li Y; Hu Z; Jordan F; Inouye M
J Biol Chem; 1995 Oct; 270(42):25127-32. PubMed ID: 7559646
[TBL] [Abstract][Full Text] [Related]
13. Conformation of the primary binding loop folded through an intramolecular interaction contributes to the strong chymotrypsin inhibitory activity of the chymotrypsin inhibitor from Erythrina variegata seeds.
Iwanaga S; Nagata R; Miyamoto A; Kouzuma Y; Yamasaki N; Kimura M
J Biochem; 1999 Jul; 126(1):162-7. PubMed ID: 10393334
[TBL] [Abstract][Full Text] [Related]
14. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
Ballinger MD; Tom J; Wells JA
Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
[TBL] [Abstract][Full Text] [Related]
15. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
Hiraga K; Suzuki T; Oda K
J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
[TBL] [Abstract][Full Text] [Related]
16. Contribution of long-range electrostatic interactions to the stabilization of the catalytic transition state of the serine protease subtilisin BPN'.
Jackson SE; Fersht AR
Biochemistry; 1993 Dec; 32(50):13909-16. PubMed ID: 8268166
[TBL] [Abstract][Full Text] [Related]
17. Effects of deletion in the flexible loop of the protease inhibitor SSI (Streptomyces subtilisin inhibitor) on interactions with proteases.
Kojima S; Furukubo S; Kumagai I; Miura K
Protein Eng; 1993 Apr; 6(3):297-303. PubMed ID: 8506264
[TBL] [Abstract][Full Text] [Related]
18. Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding.
Pantoliano MW; Whitlow M; Wood JF; Dodd SW; Hardman KD; Rollence ML; Bryan PN
Biochemistry; 1989 Sep; 28(18):7205-13. PubMed ID: 2684274
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action.
Kojima S; Deguchi M; Miura K
J Mol Biol; 1999 Feb; 286(3):775-85. PubMed ID: 10024450
[TBL] [Abstract][Full Text] [Related]
20. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
Brömme D; Fittkau S
Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
